Latest News

MAY 17, 2019 Agenda Item Request for the Extraordinary Shareholders' Meeting of New Venturetec Ltd. of June 27, 2019 MORE
MAY 04, 2019 New Venturetec Ltd. results for the first half of the fiscal year 2018/2019 ended March 31, 2019 – Rescheduling of the Extraordinary Shareholders' Meeting until June 27, 2019 MORE
APRIL 17, 2019 New Venturetec's Major Investment, Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc MORE
APRIL 15, 2019 Conversion of Convertible Note CHF 12 Mio. held by Friedli Corporate Finance GmbH, Zug MORE

Stock Info

Stock Price, April 30, 2019: CHF 8.90
Net Asset Value, April 30, 2019: CHF 12.05
Performance year to date: +71.15%